We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+46.64%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$642M
AUM Growth
+$78M
Cap. Flow
-$52.1M
Cap. Flow %
-8.12%
Top 10 Hldgs %
10.61%
Holding
350
New
118
Increased
46
Reduced
65
Closed
119

Sector Composition

Rank Sector Weight
1 Industrials 26.28%
2 Healthcare 22.97%
3 Technology 20.59%
4 Consumer Discretionary 13.24%
5 Financials 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFM icon
126
Sprouts Farmers Market
SFM
$8.01B
$2.79M 0.43%
43,202
-17,456
-29% -$973K
VRNS icon
127
Varonis Systems
VRNS
$5B
$2.78M 0.43%
59,019
-46,129
-44% -$2.2M
ICHR icon
128
Ichor Holdings
ICHR
$2.56B
$2.77M 0.43%
+71,727
New +$2.78M
SLNO
129
DELISTED
Soleno Therapeutics
SLNO
$2.76M 0.43%
64,411
-29,014
-31% -$1.31M
XPO icon
130
XPO
XPO
$23.7B
$2.75M 0.43%
22,567
-23,458
-51% -$2.51M
COHR icon
131
Coherent
COHR
$74.2B
$2.74M 0.43%
+45,133
New +$2.47M
IRON icon
132
Disc Medicine
IRON
$2.97B
$2.73M 0.43%
43,806
-9,089
-17% -$589K
VERA icon
133
Vera Therapeutics
VERA
$2.36B
$2.71M 0.42%
+62,843
New +$2.24M
NUVL
134
DELISTED
Nuvalent
NUVL
$2.63M 0.41%
34,981
-15,199
-30% -$1.21M
FN icon
135
Fabrinet
FN
$20.1B
$2.62M 0.41%
13,855
-15,901
-53% -$3.19M
IMVT icon
136
Immunovant
IMVT
$8.25B
$2.24M 0.35%
69,241
-41,688
-38% -$1.52M
JANX icon
137
Janux Therapeutics
JANX
$967M
$2.11M 0.33%
+55,973
New +$1.22M
ROOT icon
138
Root
ROOT
$798M
$1.62M 0.25%
+26,466
New +$623K
DAVE icon
139
Dave Inc
DAVE
$4.06B
$1.45M 0.23%
+38,910
New +$897K
CYBR
140
DELISTED
CyberArk
CYBR
$1.44M 0.22%
5,425
WIX icon
141
WIX.com
WIX
$2.52B
$1.4M 0.22%
10,190
EVER icon
142
EverQuote
EVER
$906M
$1.38M 0.21%
74,227
+9,579
+15% +$141K
TALK icon
143
Talkspace
TALK
$874M
$1.36M 0.21%
380,553
+47,968
+14% +$130K
NVMI
144
Nova
NVMI
$12.5B
$1.35M 0.21%
+7,626
New +$1.2M
BYRN icon
145
Byrna Technologies
BYRN
$101M
$1.28M 0.2%
+91,781
New +$889K
ESOA icon
146
Energy Services of America
ESOA
$292M
$1.27M 0.2%
154,387
+18,316
+13% +$135K
CLS icon
147
Celestica
CLS
$36.5B
$1.26M 0.2%
28,072
-18,647
-40% -$708K
TRAK icon
148
ReposiTrak
TRAK
$159M
$1.26M 0.2%
79,451
+9,425
+13% +$124K
MNDY icon
149
monday.com
MNDY
$3.94B
$1.21M 0.19%
+5,375
New +$1.14M
UTI icon
150
Universal Technical Institute
UTI
$1.59B
$1.19M 0.18%
74,453
-478
-0.6% -$6.94K

Similar funds

EAM Investors's Q1 2024 Portfolio in Review

As of Q1 2024, EAM Investors held 350 positions worth $642M, up 14% from $564M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

EAM Investors withdrew a net $52.1M in Q1 2024, closing 119 positions and reducing 65 holdings. Its most notable exit was MACOM Technology Solutions, an estimated $4.91M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

Against the trend, EAM Investors opened a new position in Ryman Hospitality Properties worth $5.03M.

  • EAM Investors's largest Q1 2024 buy was Ryman Hospitality Properties: 43,500 shares worth $5.03M.
  • EAM Investors added most to MoneyLion Inc. in Q1 2024, an estimated $2.13M increase.
  • EAM Investors's biggest Q1 2024 reduction was Viking Therapeutics, cutting an estimated $4.27M.
  • EAM Investors fully exited MACOM Technology Solutions in Q1 2024, selling an estimated $4.91M.
  • EAM Investors's ten largest holdings make up 11% of its $642M portfolio in Q1 2024.
  • EAM Investors opened 118 new positions and closed 119 in Q1 2024.
  • EAM Investors's portfolio value rose 14% quarter-over-quarter to $642M.

Based on EAM Investors's 13F filing for Q1 2024, filed 13 May 2024.